ISPC
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B is the only positive metric, but it is likely a lagging indicator of eroding assets.
- Low Price-to-Book (0.41)
- No Graham Number available
- P/S ratio of 1.97 is high given the revenue collapse
Growth rates are catastrophic and suggest a failing business model.
- Revenue growth -96.50%
- Q/Q Revenue growth -96.49%
Historical price performance shows a total loss of investor confidence.
- 5Y Change -99.9%
- 1Y Change -89.9%
The Piotroski score confirms the company is in the weakest possible health bracket.
- Low Debt/Equity
- Piotroski F-Score 1/9
- ROE -327.77%
Company is not in a position to return capital.
- No dividend yield
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ISPC and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ISPC
iSpecimen Inc.
Primary
|
-99.9% | -99.5% | -89.9% | -85.3% | -46.7% | -9.9% |
|
ACON
Aclarion, Inc.
Peer
|
-100.0% | -100.0% | -82.0% | -56.9% | +22.9% | +1.8% |
|
JAGX
Jaguar Health, Inc.
Peer
|
-100.0% | -100.0% | -92.8% | -82.2% | -34.7% | -7.8% |
|
HCTI
Healthcare Triangle, Inc.
Peer
|
-100.0% | -100.0% | -99.9% | -98.6% | -21.6% | -2.8% |
|
INBS
Intelligent Bio Solutions Inc.
Peer
|
-100.0% | -99.3% | -79.8% | -77.0% | -39.7% | -10.6% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ISPC
iSpecimen Inc.
|
BEARISH | $3.8M | - | -327.8% | -% | $0.13 | |
|
ACON
Aclarion, Inc.
|
BEARISH | $3.51M | - | -97.7% | -% | $3.33 | Compare |
|
JAGX
Jaguar Health, Inc.
|
BEARISH | $4.58M | - | -% | -% | $0.37 | Compare |
|
HCTI
Healthcare Triangle, Inc.
|
BEARISH | $2.77M | - | -183.0% | -48.8% | $2.4 | Compare |
|
INBS
Intelligent Bio Solutions Inc.
|
BEARISH | $4.92M | - | -150.2% | -% | $2.46 | Compare |
Past News Coverage
Recent headlines mentioning ISPC from our newsroom.